Grace, Peter M
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
- UT MD Anderson Cancer Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,417
- Rising Star
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$986K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,417
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Grace, Peter M as a PI. Multi-PI records show the full award amount for context.
- 5R01NS126252-02R01Contact PIRegulation of Peripheral Neuropathic Pain by B Cells$626.6Kaward amount
- 5R01CA227064-06R01Contact PIPQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and ChemobrainUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$359.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Grace, Peter M as a PI.
FY2023 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardUT MD Anderson Cancer Center
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #1142
- 2019Entered Top 25% NationallyRanked #1142
- 2019Entered Top 10% NationallyRanked #1142
- 2021R01 Grant Holder
- 2023$5M Cumulative Funding